United States · FDA National Drug Code directory
Insulizen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80353-451_4e3805b9-f7bf-4d36-e063-6294a90a51ff
- Product NDC
- 80353-451
- Form
- CAPSULE
- Composition / generic term
- Insulin Resistance Reducer, Insulin Receptor Restore, and Blood Sugar Level Balance
- Labeler
- HCBIOPHARM LLC
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20211124
- Source listing expiry
- 20271231
Source-listed ingredients
- LAGERSTROEMIA SPECIOSA LEAF — 1 [hp_X]/1
- MORINDA CITRIFOLIA FRUIT — 1 [hp_X]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 BOX (80353-451-01) / 1 CAPSULE in 1 BOTTLE (80353-451-02) / 60 CAPSULE in 1 CAPSULE (80353-451-03) · 80353-451-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →